The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Kyowa Hakko Kirin
Travel, Accommodations, Expenses - Kyowa Hakko Kirin
Time to next treatment in patients with previously treated cutaneous T-cell lymphoma (CTCL) receiving mogamulizumab or vorinostat: A MAVORIC post-hoc analysis.
 
Barbara Pro
Honoraria - Celgene; kiowa; Seagen; Takeda
Research Funding - Celgene (Inst); takeda (Inst)
Travel, Accommodations, Expenses - Seagen; takeda
 
Youn H. Kim
Consulting or Advisory Role - Actelion; Eisai; Innate Pharma; Kyowa Hakko Kirin; Medivir; Millennium; miRagen; Seagen
Research Funding - Eisai (Inst); Forty Seven (Inst); Horizant (Inst); Innate Pharma (Inst); Kyowa Hakko Kirin (Inst); Merck (Inst); Millennium (Inst); miRagen (Inst); miRagen (Inst); Neumedicines (Inst); Portola Pharmaceuticals (Inst); Seagen (Inst); Soligenix (Inst)
Patents, Royalties, Other Intellectual Property - Royalty for Chapters in UpToDate
Travel, Accommodations, Expenses - Innate Pharma
 
Pablo L. Ortiz-Romero
Consulting or Advisory Role - 4SC; Actelion; Innate Pharma; Kyowa Hakko Kirin; miRagen; Takeda
Patents, Royalties, Other Intellectual Property - PLCG1 mutation patented by my group
Travel, Accommodations, Expenses - Almirall; Janssen; Leo Pharma; Novartis
 
Lubomir Sokol
Consulting or Advisory Role - Celgene; Seagen; Spectrum Pharmaceuticals
 
Julia Scarisbrick
Honoraria - 4SC; Kyowa Hakko Kirin; Mallinckrodt; Takeda
Consulting or Advisory Role - 4SC; Innate Pharma; Kyowa Hakko Kirin; Mallinckrodt; Takeda
Research Funding - Kyowa Hakko Kirin; Takeda
 
Amy Musiek
Consulting or Advisory Role - Actelion; Kyowa Hakko Kirin; Seagen
Speakers' Bureau - Actelion; Helsinn Healthcare
Research Funding - Actelion; elorac; Helsinn Healthcare; Kyowa Hakko Kirin; miRagen; Pfizer; Soligenix
 
Maarten Vermeer
Consulting or Advisory Role - Innate Pharma; Kyowa Hakko Kirin
Research Funding - TEVA (Inst)
 
Reinhard Dummer
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sanofi; Sun Pharma; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sanofi; Sun Pharma; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
 
Ahmad Sami Halwani
Research Funding - Abbvie; Abbvie/Genentech; Amgen; Bristol-Myers Squibb; Genentech; Immune Design; Kyowa Hakko Kirin; miRagen; Pharmacyclics; Roche/Genentech; Seagen; Takeda
Travel, Accommodations, Expenses - Abbvie; Immune Design; Pharmacyclics; Seagen
 
Maria Teresa Fierro
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Junji Moriya
Employment - Kyowa Hakko Kirin
 
Mollie Leoni
No Relationships to Disclose
 
Martine Bagot
Stock and Other Ownership Interests - Innate Pharma
Consulting or Advisory Role - Innate Pharma; Kyowa Hakko Kirin; miRagen
Patents, Royalties, Other Intellectual Property - Innate Pharma